Literature DB >> 23307114

Progesterone treatment before experimental hypoxia-ischemia enhances the expression of glucose transporter proteins GLUT1 and GLUT3 in neonatal rats.

Xinjuan Li1, Hua Han, Ruanling Hou, Linyu Wei, Guohong Wang, Chaokun Li, Dongliang Li.   

Abstract

Progesterone is an efficient candidate for treating stroke and traumatic brain damage. The current study was designed to investigate the effects of progesterone on glucose transporter proteins (GLUT1 and GLUT3) during hypoxic-ischemic injury in a neonatal rat model. We demonstrated strong staining for GLUT1 in the walls of blood vessels and GLUT3 immunoreactivity in hippocampal neurons after hypoxiaischemia. Hypoxia-ischemia elevated GLUT1 and GLUT3 at both the mRNA and protein levels in the hippocampus, and pre-treatment with progesterone (8 mg/kg) further enhanced their accumulation until 24 h after hypoxic-ischemic injury. These results showed that progesterone treatment induced the accumulation of both GLUT1 and GLUT3 transporters, and an energy-compensation mechanism may be involved in the neuroprotective effect of progesterone during hypoxic-ischemic injury after cerebral ischemic attacks.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23307114      PMCID: PMC5561836          DOI: 10.1007/s12264-013-1298-y

Source DB:  PubMed          Journal:  Neurosci Bull        ISSN: 1995-8218            Impact factor:   5.203


  28 in total

Review 1.  Pathobiology of ischaemic stroke: an integrated view.

Authors:  U Dirnagl; C Iadecola; M A Moskowitz
Journal:  Trends Neurosci       Date:  1999-09       Impact factor: 13.837

2.  17 beta-Estradiol modulation of glucose transporter 1 expression in blood-brain barrier.

Authors:  J Shi; J W Simpkins
Journal:  Am J Physiol       Date:  1997-06

3.  Insulin sensitivity in streptozotocin-induced diabetic rats treated with different doses of 17beta-oestradiol or progesterone.

Authors:  Patricia Ordóñez; María Moreno; Ana Alonso; Rebeca Fernández; Fernando Díaz; Celestino González
Journal:  Exp Physiol       Date:  2006-10-26       Impact factor: 2.969

4.  Inducible astrocytic glucose transporter-3 contributes to the enhanced storage of intracellular glycogen during reperfusion after ischemia.

Authors:  Sadahiro Iwabuchi; Koichi Kawahara
Journal:  Neurochem Int       Date:  2011-06-15       Impact factor: 3.921

5.  Estrogen augments glucose transporter and IGF1 expression in primate cerebral cortex.

Authors:  C M Cheng; M Cohen; J Wang; C A Bondy
Journal:  FASEB J       Date:  2001-04       Impact factor: 5.191

6.  Insulin regulates neuronal glucose uptake by promoting translocation of glucose transporter GLUT3.

Authors:  Etsuro Uemura; Heather West Greenlee
Journal:  Exp Neurol       Date:  2005-12-09       Impact factor: 5.330

7.  Ethanol impairs glucose uptake by human astrocytes and neurons: protective effects of acetyl-L-carnitine.

Authors:  P M Abdul Muneer; Saleena Alikunju; Adam M Szlachetka; Aaron J Mercer; James Haorah
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2011

8.  Neuronal gap junctions are required for NMDA receptor-mediated excitotoxicity: implications in ischemic stroke.

Authors:  Yongfu Wang; Janna V Denisova; Ki Sung Kang; Joseph D Fontes; Bao Ting Zhu; Andrei B Belousov
Journal:  J Neurophysiol       Date:  2010-10-13       Impact factor: 2.714

9.  Overexpression of the glucose transporter gene with a herpes simplex viral vector protects striatal neurons against stroke.

Authors:  M S Lawrence; G H Sun; D M Kunis; T C Saydam; R Dash; D Y Ho; R M Sapolsky; G K Steinberg
Journal:  J Cereb Blood Flow Metab       Date:  1996-03       Impact factor: 6.200

10.  17beta-Estradiol and/or progesterone protect from insulin resistance in STZ-induced diabetic rats.

Authors:  P Ordóñez; M Moreno; A Alonso; P Llaneza; F Díaz; C González
Journal:  J Steroid Biochem Mol Biol       Date:  2008-07-09       Impact factor: 4.292

View more
  7 in total

1.  Nicotine and electronic cigarette (E-Cig) exposure decreases brain glucose utilization in ischemic stroke.

Authors:  Ali E Sifat; Bhuvaneshwar Vaidya; Mohammad A Kaisar; Luca Cucullo; Thomas J Abbruscato
Journal:  J Neurochem       Date:  2018-10-18       Impact factor: 5.372

2.  Effects of progesterone on the neonatal brain following hypoxia-ischemia.

Authors:  Rafael Bandeira Fabres; Luciana Abreu da Rosa; Samir Khal de Souza; Ana Lucia Cecconello; Amanda Stapenhorst Azambuja; Eduardo Farias Sanches; Maria Flavia Marques Ribeiro; Luciano Stürmer de Fraga
Journal:  Metab Brain Dis       Date:  2018-01-23       Impact factor: 3.584

3.  Ovarian steroids influence cerebral glucose transporter expression in a region- and isoform-specific pattern.

Authors:  C S Harrell; J Burgado; S D Kelly; G N Neigh
Journal:  J Neuroendocrinol       Date:  2014-04       Impact factor: 3.627

Review 4.  Pharmacological approaches to intervention in hypomyelinating and demyelinating white matter pathology.

Authors:  Li-Jin Chew; Cynthia A DeBoy
Journal:  Neuropharmacology       Date:  2015-06-24       Impact factor: 5.250

5.  Effects of Chronic Arginase Inhibition with Norvaline on Tau Pathology and Brain Glucose Metabolism in Alzheimer's Disease Mice.

Authors:  Baruh Polis; Margherita Squillario; Vyacheslav Gurevich; Kolluru D Srikanth; Michael Assa; Abraham O Samson
Journal:  Neurochem Res       Date:  2022-01-31       Impact factor: 3.996

6.  Difference in transient ischemia-induced neuronal damage and glucose transporter-1 immunoreactivity in the hippocampus between adult and young gerbils.

Authors:  Seung Min Park; Jae-Chul Lee; Bai Hui Chen; Bich-Na Shin; Jeong Hwi Cho; In Hye Kim; Joon Ha Park; Moo-Ho Won; Ji Hyeon Ahn; Hyun-Jin Tae; Myoung Cheol Shin; Chan Woo Park; Jun Hwi Cho; Hui Young Lee
Journal:  Iran J Basic Med Sci       Date:  2016-05       Impact factor: 2.699

7.  Progesterone Reduces ATP-Induced Pyroptosis of SH-SY5Y Cells.

Authors:  Chang Cui; Xiaona Wang; Siyu Zhang; Hui Wu; Meijie Li; Luoxiao Dong; Chongshuai Yan; Dongliang Li
Journal:  Biomed Res Int       Date:  2022-08-12       Impact factor: 3.246

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.